Catecholamines in Post-Traumatic Stress Disorder

Abstract

The purpose of these studies is to test the hypothesis that adrenergic and dopaminergic signaling contribute to consolidation (and possibly reconsolidation) of fear memory in a redundant manner by stimulation of beta2-adrenergic and the D1-class of dopaminergic receptors in the basolateral amygdala. Combined pharmacologic and genetic studies in mice have examined the above hypothesis for the consolidation of fear memory. The results are in agreement with the hypothesis. Roles for these signaling pathways in reconsolidation are not as clear, as combined treatment does not appear to influence reconsolidation. Current results indicate that treatment with beta-adrenergic receptor antagonists (beta-blockers) alone shortly after trauma is unlikely to prevent the development of PTSD. However, combination therapy of blockers and D1 receptor antagonists shortly after trauma may reduce the incidence of PTSD.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jul 01, 2012
Accession Number
ADA585061

Entities

People

  • Steven A. Thomas

Organizations

  • University of Pennsylvania

Tags

DTIC Thesaurus Topics

  • Acquisition
  • Anxiety Disorders
  • Brain
  • Catecholamines
  • Chemistry
  • Combination Therapy
  • Diseases And Disorders
  • Experimental Design
  • Health Services
  • Medical Personnel
  • Neurosciences
  • Norepinephrine
  • Therapy
  • Three Dimensional
  • Traumatic Stress Disorder

Fields of Study

  • Biology
  • Psychology

Readers

  • Cardiovascular Physiology
  • Neuroscience
  • Psychological Intervention/Treatment for Stress, Anxiety, PTSD, and Related Emotional and Cognitive Health Symptoms.

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech